ELP4 inhibitors are a class of chemical compounds that specifically target the activity of the ELP4 protein, a subunit of the Elongator complex. The Elongator complex is a multi-protein assembly involved in various cellular processes, primarily the modification of transfer RNA (tRNA) and the regulation of gene expression at the transcriptional level. ELP4 plays a critical role in facilitating the proper functioning and structural stability of the Elongator complex, which ultimately affects the modification of tRNAs and mRNA transcription elongation. Inhibitors of ELP4 work by disrupting its interaction within the Elongator complex or interfering with its ability to perform its functions, thereby affecting downstream processes that depend on Elongator activity. Such disruption can result in altered gene expression patterns, changes in protein synthesis, and potential downstream cellular effects.
The chemical structure of ELP4 inhibitors varies, but they typically possess features that enable them to selectively bind to the ELP4 protein or its binding partners in the Elongator complex. These inhibitors are designed to either mimic the natural substrates or interactors of ELP4, or alternatively, to destabilize its configuration and thus inhibit its function. Some ELP4 inhibitors exhibit high specificity for ELP4 itself, while others may have broader activity across the Elongator complex. The design of these molecules often leverages structural insights into the Elongator complex, which provides critical information for the development of small molecules or peptides that can effectively inhibit ELP4. Given the fundamental role of the Elongator complex in cellular processes such as transcription and translation, ELP4 inhibitors provide valuable tools for exploring the complex's molecular function and the consequences of its perturbation on cellular physiology and molecular pathways.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcriptional elongation by targeting positive transcription elongation factor b (P-TEFb). | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Targets RNA polymerase II and inhibits transcriptional elongation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor that can influence transcriptional elongation by altering chromatin structure. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
CDK9 inhibitor that affects transcriptional elongation by inhibiting P-TEFb. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA synthesis, affecting transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Can influence histone acetylation, which can indirectly modulate transcriptional elongation. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Histone acetyltransferase inhibitor that can affect transcriptional processes. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Inhibits histone acetyltransferases, affecting chromatin structure and transcription. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
Histone acetyltransferase inhibitor, affecting transcription. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
HDAC3-specific inhibitor that can affect transcription and chromatin structure. | ||||||